T-cell study adds to debate over duration of COVID-19 immunity

A small but key UK study has found that "cellular immunity" to the pandemic SARS-CoV-2 virus is present after six months in people who had mild or asymptomatic COVID-19 - suggesting they might have ...
New Atlas

Next-gen vaccine prevents up to 88% of multiple aggressive cancers

A next-generation cancer vaccine has shown stunning results in mice, preventing up to 88% of aggressive and ...

You can get shingles more than once — here's who's most at risk

In rare cases, you can get shingles a second or even a third time. This is most common in people with a weakened immune system.

Nobel Prize 2025: Scientists Decipher Immune System's Self-Defense, Opening Door To New Therapies

The 2025 Nobel Prize in Physiology or Medicine awarded to a trio of researchers for their work on peripheral immune tolerance ...